It's too early (or too hard) to tell right now what Genzyme's true value is

sanofi-aventis is lowballing with its $18.5 billion bid, and Genzyme should hold out

Genzyme thinks too highly of its value and should take the $18.5 billion offer from sanofi-aventis

Other: